Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000178

Chief People Officer gave up 9,004 shares (to pay taxes)

  • Chief People Officer acquired 200,000 shares (grant or award)
  • Chief People Officer acquired 25,950 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schick Kelly · Chief People Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-13 Grant or award : show line 1 in the form +200,000 308,885 D
2026-02-13 Exercise or conversion : show line 2 in the form +5,000 308,885 D
2026-02-13 Shares withheld for taxes : show line 3 in the form −1,735 $1.89 $3,279 307,150 D
2026-02-14 Exercise or conversion : show line 4 in the form +20,950 307,150 D
2026-02-14 Shares withheld for taxes : show line 5 in the form −7,269 $1.89 $13,738 299,881 D
Loading xslF345X05/wk-form4_1771452301.xml…